Roswell Park-Developed Immunotherapy Now Part of Nationwide Study in Kids With Brain Cancer
Roswell Park is first of several sites that will offer SurVaxM to young patients in pilot study...
Read More
Author: Buffalo Healthy Living
Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia
Results on FLT3 inhibitor crenolanib in combination with chemotherapy to be presented in talk at...
Read More
Roswell Park Researchers Identify New Treatment Target for Prostate Cancer
Components of mitochondrial stress response could be key to overcoming resistant/recurrent...
Read More
Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma
Results of phase 2A single-arm trial assessing SurVaxM plus standard therapy highlighted in poster...
Read More
From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
Children’s Oncology Group study shows benefit for children and adolescents with high-risk HL...
Read More
CURRENT ISSUE
SPECIAL ISSUES
Recent Videos
